期刊文献+

经皮机械循环支持装置在重症心血管疾病中的应用进展 被引量:13

Advancement on the use of percutaneous mechanical circulatory support devices in severe cardiovascular diseases
原文传递
导出
摘要 经皮机械循环支持(PMcs)装置对心源性休克或急性失代偿性心力衰竭患者的急性期救治具有较好的疗效,是等待心脏功能恢复或为后续治疗赢得时间的“桥梁”技术。主动脉内球囊反搏(IABP)是目前应用最为广泛的PMCS装置,而Tandem-Heart跨房间隔左心室辅助装置、Impella跨主动脉瓣左心室辅助装置、体外膜肺氧合器(ECMO)等新型PMCS装置能够提供比IABP更有效的血流动力学支持。临床医师需要根据各种PMCS装置的工作原理和效应,结合患者的临床情况,选择适合患者的PMCS类型和工作模式,从而最大限度地发挥PMCS装置的循环支持功能,纠正血流动力学紊乱,使患者平稳渡过疾病危险期。 Percutaneous mechanical circulatory support (PMCS) devices are effective in the treatment of patients with cardiogenic shock and acute decompensated heart failure, as a bridge to the recovery of heart function or further treatment. The intra-aortic balloon pump (IABP) is now the most widely used PMCS. New PMCS devices including Transseptal device of Tandem-Heart, transaortic valve device of Impella and extracorporeal membrane oxygenation (ECMO) might provide more effective hemodynamic supports. Doctors should choose appropriate PMCS devices and their working modes, according to patient's clinical conditions, based on the working principles and hemodynamic effects of the devices, in order to achieve the best effects and help patients live through the crisis of diseases.
出处 《中华危重病急救医学》 CAS CSCD 北大核心 2016年第12期1161-1164,共4页 Chinese Critical Care Medicine
基金 国家自然科学基金(81400177) 北京市自然科学基金(7154249)
关键词 经皮机械循环支持装置 心血管疾病 心源性休克 心力衰竭 Percutaneous mechanical circulatory support Cardiovascular diseases Cardiogenic shock Heart failure
  • 相关文献

参考文献4

二级参考文献96

  • 1Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 2Kantrowitz A, Tjonneland S, Freed PS, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA, 1968, 203:113-118. 被引量:1
  • 3Brodie BR, Stuckey TD, Hansen C, et al. Intra-aortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in higb-risk patients with acute myocardial infarction. Am J Cardiol, 1999,84 : 18-23. 被引量:1
  • 4Cohen M, Dawson MS, Kopistansky C, et al. Sex and other predictors of intra-aortic balloon counterpulsation-relatcd complications: prospective study of 1119 consecutive patients. Am Heart J,2000 ,139 :282-287. 被引量:1
  • 5Briguori C, Sarais C, Pagnotta P, et al. Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J, 2003,145 : 700- 707. 被引量:1
  • 6Vijayalakshmi K, Kunadian B, Whittaker VJ, et al. Intra-aortic counterpulsation does not improve coronary flow early after PCI in a high-risk group of patients : observations from a randomized trial to explore its mode of action. J Invasive Cardiol, 2007,19: 339- 346. 被引量:1
  • 7Perera D, Stables R, Thomas M, et al. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA, 2010, 304: 867 -874. 被引量:1
  • 8Sjauw KD, Engstrm AE, Vis MM, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?. Eur Heart J ,2009,30:459468. 被引量:1
  • 9Unverzagt S, Machemer MT, Solms A, et al. Intra-aortic balloon pump counterpulsation ( IABP ) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev, 2011,6 : CD007398. 被引量:1
  • 10Bahekar A, Singh M, Singh S, et al. Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: a meta-analysis. Cardiovasc Pharnmcol Ther,2012,17:44-56. 被引量:1

共引文献2412

同被引文献105

引证文献13

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部